MedTrace Logo

Migraine STImulation Crisis of Migraine

NCT04568252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-03-06

No results posted yet for this study

Summary

Migraine is a neurovascular disease whose prevalence is estimated at almost 20% of the adult population. Currently, there is no treatment for migraine.

Millimeter stimulation of the wrist subcutaneous receptors allows the release of endorphin in the brain.

MISTIC is a prospective, controlled, multicenter, double-blind, randomized study in which the research team are investigating whether millimeter stimulation of subcutaneous wrist receptors reduces the frequency of migraine crisis.

Conditions

  • Migraine Without Aura

Interventions

DEVICE

Wristband with millimeter wave emission.

Wristband treatment with millimeter wave emission twice a day for 3 months.

DEVICE

Placebo of wristband with millimeter wave emission.

Treatment with a millimeter wave emission wristband placebo twice a day for 3 months.

Sponsors & Collaborators

  • Remedee SA

    lead INDUSTRY

Principal Investigators

  • Caroline MD MAINDET · CHUGA, 38000 Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-04
Primary Completion
2022-10-15
Completion
2023-01-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04568252 on ClinicalTrials.gov